Involvement of Sema4D in the control of microglia activation

Marcia Toguchi1, Daniel Gonzalez, Sohei Furukawa

  • 1Osaka University, Yamadaoka, Suita-shi, Japan.

Insights

Semaphorin4D (Sema4D/CD100) regulates microglial activation, a key immune cell in the central nervous system. This study shows Sema4D/CD100 acts as a neuroprotective factor by inhibiting harmful microglial responses.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia are crucial for central nervous system (CNS) immune surveillance but can cause neuronal damage when over-activated.
  • Uncontrolled microglial activation is implicated in various neuropathologies.

Purpose of the Study:

  • To investigate the role of Semaphorin4D (Sema4D/CD100) in regulating microglial activation.
  • To determine if Sema4D/CD100 possesses neuroprotective properties by modulating microglial responses.

Main Methods:

  • Primary microglia cultures were activated with lipopolysaccharide (LPS).
  • Cells were treated with Sema4D/CD100 or conditioned medium.
  • Intracerebral LPS injections were performed in mice lacking Sema4D/CD100.
  • Microglial morphology, nitrite production, migration, and RhoA activation were assessed.

Main Results:

  • Sema4D/CD100 significantly inhibited LPS-induced microglial morphological activation and migration.
  • Mice lacking Sema4D/CD100 exhibited increased microglial activation following intracerebral LPS injection.
  • Sema4D/CD100 treatment reduced nitrite production and modulated RhoA activation in LPS-activated microglia.
  • LPS upregulated Plexin-B1 expression in microglia, suggesting a potential interaction pathway.

Conclusions:

  • Semaphorin4D/CD100 plays a novel inhibitory role in the regulation of microglial activation.
  • Sema4D/CD100 demonstrates potential as a neuroprotective agent for the CNS.
  • Targeting Sema4D/CD100 may offer therapeutic strategies for neuropathological conditions involving microglial over-activation.

Related Concept Videos